IDH1 and central nervous system cancer: In detail, they found that somatic mutations in IDH1 at R132 or IDH2 at R172 led to increased risk of glioma, hemangiomas and chondrosarcoma, and they demonstrated that the mutated IDH contributed to the increased cell proliferation, colony formation, and inability to differentiate (7).